The emergence of matrix metalloproteinases (e.g., MMP2) and S100A9 in diabetes and steatosis prediction models further supports the role of adiposome-mediated remodeling and inflammatory signaling in these diseases [72]. This evidence concerns the gene S100A9 and steatosis.